4--[(4-Methylpiperazin-1-yl) methyl]benzoic acid dihydrochloride CAS 106261-49-8 Imatinib Mesylate Yepakati Yakanyanya Kuchena

Tsanangudzo Pfupi

4--[(4-Methylpiperazin-1-yl) methyl]benzoic Acid Dihydrochloride

CAS: 106261-49-8

Chitarisiko: Chichena kusvika Chinenge Chichena Poda kusvika kuCrystal

Kuchena: ≥98.0% (HPLC)

Pakati peImatinib Mesylate (CAS: 220127-57-1) mukurapa kwePhiladelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph + CML)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name 4- [(4-Methylpiperazin-1-yl) methyl]benzoic acid dihydrochloride
Mashoko anoreva zvakafanana Imatinib Mesylate Pakati
Nhamba yeCAS 106261-49-8
Nhamba yeCAT RF-PI229
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C13H20Cl2N2O2
Molecular Weight 307.22
Melting Point 305.0~307.0℃
Solubility Soluble mumvura
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kusvika Kunenge Ichena Hupfu kusvika kuCrystal
Kuchena / Analysis Method ≥98.0% (HPLC)
Kurasika paKuomesa ≤0.50%
Residue pamoto ≤0.50%
Zvose Zvisina Kuchena ≤2.0%
Maximum Single Kusachena ≤1.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Pakati peImatinib Mesylate (CAS: 220127-57-1)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi we4--[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (CAS: 106261-49-8) ine mhando yepamusoro.Itiri yepakati kazhinji mune synthesis yeImatinib Mesylate (CAS: 220127-57-1).Imatinib Mesylate inonzi tyrosine kinase inhibitor, yakanyanya kunyanya kuBCR-ABL, mushonga wemuromo wekurapa varwere vakuru vane Philadelphia chromosome positive chronic myeloid leukemia (CML) muchikamu chepamusoro uye mamwe maitiro e acute lymphoblastic leukemia (ALL), yakakurumidza. chikamu uye chisingaperi chikamu mushure mekukundikana kwe interferon therapy.

Nyora meseji yako pano ugotitumira